JIANGXI FUSHINE PHARMACEUTICAL CO., LTD is a prominent pharmaceutical company engaged in research and development, production, sales, and service. Publicly traded on the Shenzhen Stock Exchange since 2015, Fushine is dedicated to manufacturing β-lactam Enzyme Inhibitors, Carbapenem, and Antivirals. With a robust focus on R&D, technology introduction, quality management, and EHS management, Fushine has established a comprehensive production chain for Penems. Over the years, the company has cultivated strong partnerships with numerous renowned pharmaceutical firms both domestically and internationally.

Services include:
- R&D of β-lactam Enzyme Inhibitors
- Production of Carbapenem
- Manufacturing of Antivirals
- Quality management and EHS management
- Technical support and service for partners

As an established player in the pharmaceutical industry, JIANGXI FUSHINE PHARMACEUTICAL CO., LTD continues to advance its capabilities and strengthen its market presence. For more information, please visit fuxiangpharm.com.